Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes
{{output}}
Background and aims: The 2019 European Society of Cardiology guidelines for the management of dyslipidemia consider the use of high-dose marine omega-3 fatty acid (FA) eicosapentaenoic acid (EPA) supplementation (icosapent ethyl ... ...
